Layer 1
All

Refine

E.g., 21/02/2019
E.g., 21/02/2019

Refine

Refine

E.g., 21/02/2019
E.g., 21/02/2019

all

Prescription charge to increase 20p to £9 in April
There will be no change to the cost of pre-paid prescription certificates (PPC), health minister Baroness Blackwood said in a statement today (...
21/02/2019 0
Prescription charge to increase 20p to £9 in April
There will be no change to the cost of pre-paid prescription certificates (PPC), health minister Baroness Blackwood said in a statement today (...
21/02/2019 0
Prescription charge to increase 20p to £9 in April
There will be no change to the cost of pre-paid prescription certificates (PPC), health minister Baroness Blackwood said in a statement today (...
21/02/2019 0
Prescription charge to increase 20p to £9 in April
There will be no change to the cost of pre-paid prescription certificates (PPC), health minister Baroness Blackwood said in a statement today (...
21/02/2019 0
Following an EU review, the MHRA is updating product information for carbimazole
New evidence of congenital malformations with carbimazole, MHRA warns
There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
21/02/2019 0
Following an EU review, the MHRA is updating product information for carbimazole
New evidence of congenital malformations with carbimazole, MHRA warns
There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
21/02/2019 0
Following an EU review, the MHRA is updating product information for carbimazole
New evidence of congenital malformations with carbimazole, MHRA warns
There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
21/02/2019 0
Following an EU review, the MHRA is updating product information for carbimazole
New evidence of congenital malformations with carbimazole, MHRA warns
There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
21/02/2019 0
Following an EU review, the MHRA is updating product information for carbimazole
New evidence of congenital malformations with carbimazole, MHRA warns
There is an increased risk of congenital malformations for women taking the anti-thyroid agent, “especially when administered in the first trimester...
21/02/2019 0
grant_revell-38868-logsheet
21/02/2019 0

Pages